GUAVA SIGNS $5.5 MILLION JAPANESE DISTRIBUTION PACT.Guava guava (gwä`və), small evergreen tree or shrub of the genus Psidium of the family Myrtaceae (myrtle family), native to tropical America and grown elsewhere for its ornamental flowers and edible fruit. Technologies Inc., Burlingame, Calif., which develops, manufactures and markets innovative cellular analysis systems, has announced a five-year, $5.5 million distribution agreement with Kobe-based Bay Bioscience bioscience /bio·sci·ence/ (-si´ens) the study of biology wherein all the applicable sciences (physics, chemistry, etc.) are applied. bi·o·sci·ence n. See life science. K.K. to manage the distribution of the Guava Personal Cytometer (Guava PC(tm)) in the Japanese market. In addition, the company closed a $6 million Series D round of funding to facilitate the Japanese expansion. "We accelerated our plans to introduce the Guava PC to Japan because of the opportunity to build market share for our platform technology," said Philippe Goix, Ph.D., president and founder of Guava. "We are pleased with the enthusiasm and support we have received from our distribution partner and our investors." "Guava's micro volume, single cell platform is the most innovative approach to cellular analysis we've seen," said Koji Murayama, the president and founder of Bay Bioscience. "We are confident that the Guava PC has the potential to revolutionize rev·o·lu·tion·ize tr.v. rev·o·lu·tion·ized, rev·o·lu·tion·iz·ing, rev·o·lu·tion·iz·es 1. To bring about a radical change in: Television has revolutionized news coverage. 2. drug discovery and other cellular analysis applications in Japan. " Bay Bioscience also invested in the company's series D financing. "Our equity investment represents the strength of our endorsement for Guava, its system, and future applications" continued Murayama. On the heels of Guava's successful Series C funding in June, Bay Bioscience gave its commitment to participate in a Series D financing round to support the infrastructure for a (more) successful Japanese deployment. Two Japanese investment firms, Yasuda Enterprise Development company and Iwakuni Foundation, led the $6 million series D round of financing along with Guava's new Japanese distributor. Other existing investors, including Abingworth Management, ProQuest Investments, and Skyline Ventures also participated in the round. Guava's first product, the Guava PC, brings sophisticated cellular analysis directly to the researcher's laboratory benchtop. The compact, portable, expandable system is capable of providing a wide range of cellular assays on a single instrument. The Guava PC combines speed, precision, accuracy and ease-of-use to increase productivity and high throughput, as well as lower research and development costs in cell biology Cell biology The study of the activities, functions, properties, and structures of cells. Cells were discovered in the middle of the seventeenth century after the microscope was invented. research. Industry analysts estimate Japan's life science research market to be the third largest in the world, following the US and Europe. The Guava PC is currently available in Japan through Bay Bioscience K.K., a leading distributor for the life science research market, headquartered in Kobe, Japan. In the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , the Guava PC is marketed by Guava's direct sales force. Guava Technologies, Inc. develops, manufactures and markets proprietary cellular analysis systems to the life science research market. Based in Burlingame, Calif., Guava was founded in 1998. Guava's core technology is a proprietary micro volume scale analysis platform, which is embodied em·bod·y tr.v. em·bod·ied, em·bod·y·ing, em·bod·ies 1. To give a bodily form to; incarnate. 2. To represent in bodily or material form: in its first product ? the Guava Personal Cytometer (Guava PC). To date, Guava, a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. , has raised $27 million of funding, principally from Abingworth Management, Bay Bioscience, Fog City Fog City can refer to:
as a missionary he fearlessly confronts the “perils of waters, of robbers, in the city, in the wilderness.” [N.T.: II Cor. 11:26] See : Bravery Venture Capital. For more information, visit http://www.guavatechnologies.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion